What’s the state of Telemedicine in Europe and the US? Our comprehensive report outlines all the key players in the space, M&A transactions, and company valuations. Download the full report below. Key highlights include:
- We note that for the first time since H2 2020 public market valuations in terms of revenue multiples increased in H1 2023 to 3.1x, below the LT average of 3.9x.
- M&A activity remained very selective with 22 transactions as the larger operators continued to consolidate the market and add new services. We see the larger groups looking to dominate their markets.
- While fund raising has declined, 121 fundraisings were completed for nearly € 1 billion as specialist investors continue to anticipate secular growth drivers for the sector including government support, aging populations, and medical diagnostic advancements.
- These same drivers are the reasons why we believe we will continue to see growth in the sector.
- We have updated our mapping of the US and EU operators in the telemedicine market, organized in five subsectors, namley remote consultation, clinician selection & e-booking tools, symptom checker & remote monitoring solutions, specialty care and remote pharmacy.
Download the full report here.
